Periodontitis (gum inflammation) is a common disease worldwide. This study aims to investigate a novel biomarker, a protein called Mitofusin-1 (Mfn1), in saliva that may be associated with the severity of periodontitis and response to treatment. The study will include periodontally healthy individuals, individuals with mild to severe periodontitis, and smokers with severe periodontitis. Participants will receive saliva samples and undergo clinical periodontal examinations. Individuals with periodontitis will receive standard periodontal treatment, and changes in Mfn1 levels will be assessed 3 months after treatment. The study is expected to shed light on the potential utility of Mfn1 as a marker in the diagnosis and follow-up of periodontitis.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
104
A standard periodontal treatment procedure that involves the removal of dental plaque and calculus (tartar) from the tooth surfaces and root pockets. This is followed by root planing to smooth the root surfaces, allowing the gingiva to heal and reattach to the tooth.
Collection of unstimulated whole saliva. Participants will be asked to allow saliva to pool in the floor of the mouth and then passively drool into a sterile collection tube. A total of 1.5 ml of saliva will be collected from each participant.
Erzincan Binali Yıldırım University Faculty of Dentistry
Erzincan, Erzincan, Turkey (Türkiye)
RECRUITINGSalivary Mitofusin-1 (Mfn1) Concentration at Baseline
Mfn1 protein concentration in saliva measured using ELISA (ng/mL) at baseline in each study group.
Time frame: Baseline
Change in Salivary Mfn1 Concentration After Periodontal Therapy
Difference in salivary Mfn1 concentration (ng/mL) measured using ELISA at baseline and 3 months after non-surgical periodontal therapy in the periodontitis groups.
Time frame: Baseline and 3 months
Salivary Glutathione Peroxidase (GPx) Concentration
GPx enzyme activity measured in saliva by spectrophotometric colorimetric assay (U/L).
Time frame: Baseline
Salivary 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) Concentration
8-OHdG concentration measured in saliva using ELISA (ng/mL).
Time frame: Baseline
Correlation Between Salivary Mfn1 Concentration and Probing Depth (PD)
Correlation coefficient (r) between salivary Mitofusin-1 (Mfn1) concentration measured by ELISA (ng/mL) and probing depth measured with a manual periodontal probe (mm).
Time frame: Baseline
Correlation Between Salivary Mfn1 Concentration and Clinical Attachment Level (CAL)
Correlation coefficient (r) between salivary Mitofusin-1 (Mfn1) concentration measured by ELISA (ng/mL) and clinical attachment level measured with a manual periodontal probe (mm).
Time frame: Baseline
Correlation Between Salivary Mfn1 Concentration and Plaque Index (PI)
Correlation coefficient (r) between salivary Mitofusin-1 (Mfn1) concentration measured by ELISA (ng/mL) and plaque index assessed using the Silness-Löe Plaque Index (%).
Time frame: Baseline
Correlation Between Salivary Mfn1 Concentration and Gingival Index (GI)
Correlation coefficient (r) between salivary Mitofusin-1 (Mfn1) concentration measured by ELISA (ng/mL) and gingival index assessed using the Löe-Silness Gingival Index (score).
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.